title: In individuals at intermediate risk for cardiovascular disease, treatment with rosuvastatin but not candesartan plus hydrochlorothiazide lowers cardiovascular disease event rates.
authors.affiliation: Department of Family and Community Medicine, University of Missouri, Columbia, Missouri, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: LeFevre
mesh_terms: D000959:Antihypertensive Agents; D002318:Cardiovascular Diseases; D006801:Humans; D006852:Hydrochlorothiazide; D006973:Hypertension; D000068718:Rosuvastatin Calcium
chemical_list: D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D000068718:Rosuvastatin Calcium